

National Health Insurance The Impact of HIV, TB and Related Diseases on a Future NHI Download full PDF Document This Policy Brief shows that much is known about the future trajectory of the HIV/AIDS epidemic from the modelling work by Prof Rob Dorrington and Dr Leigh Johnson and their colleagues at UCT. The earlier study of costs in the public sector is quoted which should form the basis for a future costing for NHI but needs updated figures. Dr Leon Regensberg and Michael Hislop at Aid for AIDS have excellent data in a variety of settings and countries. Sources of data for estimating the impact of TB are suggested and the new Johnson model of the impact of the interaction between HIV and sexually-transmitted infections is available. Units in South Africa that may be able to assist in a definitive updated costing of the impact of all aspects of the epidemic are: Centre for Actuarial Research (CaRE), University of Cape Town: http://www.commerce.uct.ac.za/Research_Units/CARE/ Aid for Aids: http://www.aidforaids.co.za/ HIV Prevention Research Unit: http://www.mrc.ac.za/hiv/hiv.htm TB Epidemiology and Intervention Research Unit: http://www.mrc.ac.za/operationaltb/index.htm The Centre for Social Science (CSSR), University of Cape Town: http://www.cssr.uct.ac.za/ Health Economics and HIV/AIDS Research Division (HEARD), University of KwaZulu-Natal: http://www.heard.org.za/ Centre for the Study of AIDS, University of Pretoria: http://www.csa.za.org/ The Centre for Health Policy (CHP), University of the Witwatersrand: http://web.wits.ac.za/Academic/Centres/CHP/Research/HIV/HIVAIDS.htm Reproductive Health and HIV Research Unit (RHRU), University of the Witwatersrand: http://www.rhru.co.za/default.asp The KwaZulu-Natal Research Institute for Tuberculosis and HIV: a new unit to be housed in the Nelson Mandela School of Medicine in Durban. In all, there are substantial resources and experienced people available to assist in producing estimates of the impact of HIV and related diseases on a future NHI. This work needs to be commissioned, however the future NHI may be structured. Produced for IMSA by Professor Heather McLeod 4 July 2009 Resources on the IMSA Web-site The following are available on the NHI section of the IMSA web-site: www.imsa.org.za The slides and tables used in this policy brief [PowerPoint slides]. Tables by age and gender of the population in each province, with tables giving the WHO staging of HIV infection and the numbers needing and discontinuing antiretroviral treatment. Tables are available from 1985 (which pre-dates the epidemic) to 2025. [Excel spreadsheets.] As the purpose of this series is to put in the public domain material and evidence that will progress the technical work of developing a National Health Insurance system, we would be delighted if you make use of it in other research and publications. All material produced for the IMSA NHI Policy Brief series and made available on the web-site may be freely used, provided the source is acknowledged. The material is produced under a Creative Commons Attribution-Noncommercial-Share Alike licence << Back to NHI Project List	Contact Details: Innovative Medicines SA Val Beaumont P.O. Box 2008 Houghton, 2041 Tel: +27 11 880-4644 Fax: +27 11 880-5987 Contact Us! IMSA: Published Profile of Member Companies and Position Statements Deloitte Final Report: Feb 2010

National Health Insurance
The Impact of HIV, TB and Related Diseases on a Future NHI

This Policy Brief shows that much is known about the future trajectory of the HIV/AIDS epidemic from the modelling work by Prof Rob Dorrington and Dr Leigh Johnson and their colleagues at UCT. The earlier study of costs in the public sector is quoted which should form the basis for a future costing for NHI but needs updated figures. Dr Leon Regensberg and Michael Hislop at Aid for AIDS have excellent data in a variety of settings and countries. Sources of data for estimating the impact of TB are suggested and the new Johnson model of the impact of the interaction between HIV and sexually-transmitted infections is available.

Units in South Africa that may be able to assist in a definitive updated costing of the impact of all aspects of the epidemic are:

Centre for Actuarial Research (CaRE), University of Cape Town: http://www.commerce.uct.ac.za/Research_Units/CARE/
Aid for Aids: http://www.aidforaids.co.za/
HIV Prevention Research Unit: http://www.mrc.ac.za/hiv/hiv.htm
TB Epidemiology and Intervention Research Unit: http://www.mrc.ac.za/operationaltb/index.htm
The Centre for Social Science (CSSR), University of Cape Town: http://www.cssr.uct.ac.za/
Health Economics and HIV/AIDS Research Division (HEARD), University of KwaZulu-Natal: http://www.heard.org.za/
Centre for the Study of AIDS, University of Pretoria: http://www.csa.za.org/
The Centre for Health Policy (CHP), University of the Witwatersrand:

http://web.wits.ac.za/Academic/Centres/CHP/Research/HIV/HIVAIDS.htm

Reproductive Health and HIV Research Unit (RHRU), University of the Witwatersrand: http://www.rhru.co.za/default.asp
The KwaZulu-Natal Research Institute for Tuberculosis and HIV: a new unit to be housed in the Nelson Mandela School of Medicine in Durban.

In all, there are substantial resources and experienced people available to assist in producing estimates of the impact of HIV and related diseases on a future NHI. This work needs to be commissioned, however the future NHI may be structured.

Produced for IMSA by
Professor Heather McLeod
4 July 2009

Resources on the IMSA Web-site

The following are available on the NHI section of the IMSA web-site: www.imsa.org.za

The slides and tables used in this policy brief [PowerPoint slides].
Tables by age and gender of the population in each province, with tables giving the WHO staging of HIV infection and the numbers needing and discontinuing antiretroviral treatment. Tables are available from 1985 (which pre-dates the epidemic) to 2025. [Excel spreadsheets.]

As the purpose of this series is to put in the public domain material and evidence that will progress the technical work of developing a National Health Insurance system, we would be delighted if you make use of it in other research and publications. All material produced for the IMSA NHI Policy Brief series and made available on the web-site may be freely used, provided the source is acknowledged. The material is produced under a Creative Commons Attribution-Noncommercial-Share Alike licence

<< Back to NHI Project List

Contact Details:

Innovative Medicines SA
Val Beaumont

P.O. Box 2008
Houghton, 2041

Tel: +27 11 880-4644

Fax: +27 11 880-5987

IMSA: Published Profile of Member Companies and Position Statements

Deloitte Final Report: Feb 2010

National Health InsuranceThe Impact of HIV, TB and Related Diseases on a Future NHI

Resources on the IMSA Web-site

Contact Details:

National Health Insurance
The Impact of HIV, TB and Related Diseases on a Future NHI